News

US judge approves Bayer's $7.25 billion cancer settlement

DW

A US judge on Friday approved German chemical giant Bayer's $7.25 billion (€6.60 billion) settlement of lawsuits claiming its Roundup weedkiller causes cancer. Judge Timothy Boyer in the US state of Missouri ruled that the agreement was "fair, reasonable, and adequate." The decision could help Bayer end years of costly legal battles over Roundup, which the company acquired when it bought US weedkiller producer Monsanto in 2018. "The court's final approval is a decisive milestone in the company's strategy to mitigate the risks of both pending and future Roundup litigation," Bayer CEO Bill Anderson said. The agreement covers tens of thousands of people who say they developed non-Hodgkin lymphoma, a type of blood cancer, after using Roundup.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.